From the Wolfson Institute for Biomedical Research, University College London, WC1E 6BT London, United Kingdom.
J Biol Chem. 2013 Nov 15;288(46):32922-31. doi: 10.1074/jbc.M113.481507. Epub 2013 Oct 1.
TNF-related apoptosis-inducing ligand (TRAIL) holds promise for treatment of cancer due to its ability to selectively kill cancer cells while sparing normal cells. Ligand-induced translocation of TRAIL receptors (TRAIL-R) 1 and 2 (also called DR4 and DR5, respectively) into lipid raft membrane microdomains is required for TRAIL-induced cell death by facilitating receptor clustering and formation of the death-inducing signaling complex, yet the underlying regulatory mechanisms remain largely unknown. We show here that the non-receptor tyrosine kinase Ack1, previously implicated in the spatiotemporal regulation of the EGF receptor, is required for TRAIL-induced cell death in multiple epithelial cell lines. TRAIL triggered a transient up-regulation of Ack1 and its recruitment to lipid rafts along with TRAIL-R1/2. siRNA-mediated depletion of Ack1 disrupted TRAIL-induced accumulation of TRAIL-R1/2 in lipid rafts and efficient recruitment of caspase-8 to the death-inducing signaling complex. Pharmacological inhibition of Ack1 did not affect TRAIL-induced cell death, indicating that Ack1 acts in a kinase-independent manner to promote TRAIL-R1/2 accumulation in lipid rafts. These findings identify Ack1 as an essential player in the spatial regulation of TRAIL-R1/2.
肿瘤坏死因子相关凋亡诱导配体(TRAIL)因其能够选择性地杀死癌细胞而不伤害正常细胞,因此有望用于癌症治疗。配体诱导的 TRAIL 受体(TRAIL-R)1 和 2(分别称为 DR4 和 DR5)向脂筏膜微域的易位是 TRAIL 诱导细胞死亡所必需的,因为它促进了受体聚集和死亡信号转导复合物的形成,但潜在的调节机制在很大程度上仍然未知。我们在这里表明,先前涉及表皮生长因子受体时空调节的非受体酪氨酸激酶 Ack1,是多种上皮细胞系中 TRAIL 诱导细胞死亡所必需的。TRAIL 触发 Ack1 的短暂上调及其与 TRAIL-R1/2 一起向脂筏的募集。siRNA 介导的 Ack1 耗竭破坏了 TRAIL 在脂筏中诱导的 TRAIL-R1/2 积累和 caspase-8 向死亡信号转导复合物的有效募集。Ack1 的药理学抑制不影响 TRAIL 诱导的细胞死亡,表明 Ack1 以激酶非依赖性方式促进 TRAIL-R1/2 在脂筏中的积累。这些发现确定 Ack1 是 TRAIL-R1/2 空间调节中的一个重要参与者。